THIOTRIAZOLIN Pharmaceutical form Tablets. Composition 1 tablet contains 0.1 g of thiotriazoline, equivalent to 100% substance; excipients: microcrystalline cellulose, low molecular weight polyvinyl pyrrolidone (medical grade), powdered sugar, potato starch, calcium stearate. Indications Chronic hepatites of various etiology, liver cirrhosis. Ischemic heart disease: acute macro- and microfocal myocardial infarction, angina of effort, angina at rest, postinfarction cardiosclerosis, heart rhythm disorders. Contraindications Hypersensitivity to the components of the drug; renal failure, children under 5 years of age; pregnancy and lactation Dosage and administration For hepatic diseases, adults are usually prescribed 1 – 2 tablets 3 - 4 times daily for 20 - 30 days. For angina of effort and angina at rest, myocardial infarction, postinfarction cardiosclerosis - 1 – 2 tablets 3 - 4 times daily for 20 - 30 days. For heart rhythm disorders - 1 - 2 tablets orally or sublingually 3 times daily. Children are prescribed 10-20 mg of Thiotriazolin per kilogram of the bodyweight daily in 3 divided doses. The duration of therapy should be determined by a physician on an individual basis depending on the severity and clinical presentation of the disease. Side effects When used in therapeutic doses, adverse reactions have not been reported.